Enterprise AI knowledge. From a team who ships it.

An updated view of the enterprise AI technology landscape. What mature enterprise AI architecture looks like now, and what's different from a year ago.

AI student support: personalised, available, and consistent. What happens when education data expertise meets adoption science in building tools students actually use.

Agentic AI workflows that actually run in production. Architecture patterns, error handling, observability, and the lessons from deploying autonomous AI systems in enterprise environments.

Zoubeir Jlassi, a graphic designer from Tunisia, beat 3,500 entries to win Google's $1 million AI Film Award. He used generative AI for characters, animation, narration, and post-production. The barriers to filmmaking just disappeared.

AI data centres now consume 90 terawatt-hours per year, roughly 10x the 2022 figure. AI-optimised racks demand 30-100 kW each. The hunger for power is so extreme it has restarted growth in a stagnant US electrical grid.

Looking ahead at platform maturity, compound value, and the operational shift. What we expect from enterprise AI in the year ahead.

Neuralink's first UK patient controlled a computer just hours after receiving a brain implant. Not weeks of training. Hours. The brain-computer latency is collapsing faster than anyone predicted.

The AI companion market hit $366 billion. 83% of Gen Z believe they could form deep emotional bonds with AI. Character.AI's average user has 25 sessions per day. Seven families sued OpenAI after teen deaths. The numbers demand attention.

New Zealand's AI landscape has shifted from experimentation to execution. Adoption rates are up, governance is maturing, and the gap between leaders and laggards is widening fast.

AI-native isn't about having AI tools. It's about AI being embedded in how an organisation operates, decides, and learns. Here's what that actually looks like.

The Mirai algorithm can predict breast cancer risk from a single mammogram up to five years before visible signs. An NHS study of 175,000 women found it caught 25% of cancers that human radiologists missed entirely.

Synthetic biology is closer to enterprise relevance than most think. Drug discovery, materials, agriculture. The early signals that matter.